Company / Revenue per Share
Day One Biopharmaceuticals, Inc. Revenue per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.56
FY2025
5-year range
$0.00 / $1.56
FY2022-FY2025
Trend
+4.0%
vs FY2024
Sector context
#96 of 152
Health Care
What the data says
At $1.56, Day One Biopharmaceuticals, Inc.'s revenue per share ranks #96 of 152 in the Health Care sector. Improved from $0.00 to $1.56 over the past 2 years.
Based on SEC 10-K filings.
1.56 in FY2025.
Improved from $0.00 to $1.56 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#96 of 152 in Health CareTop 63% of 152This company $1.56 Sector average $10.34
▼
-84.9% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 4.0% year-over-year.
- Ranks #96 out of 152 companies in the Health Care sector.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.56 | +4.0% |
| FY2024 | $1.50 | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026